No Data
No Data
Nervonik Raises $13 Million in Series A Financing to Advance Next-Generation Peripheral Nerve Stimulation for Chronic Pain Relief
UBS Maintains Inspire Medical Systems(INSP.US) With Buy Rating, Maintains Target Price $265
RBC Capital Maintains Inspire Medical Systems(INSP.US) With Buy Rating, Maintains Target Price $260
3 Big Reasons to Love Inspire Medical Systems (INSP)
Should You Think About Buying Inspire Medical Systems, Inc. (NYSE:INSP) Now?
Inspire Medical Systems Insider Sold Shares Worth $4,694,766, According to a Recent SEC Filing